CS1-CAR T Cells
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 30 patients (estimated)
- Sponsors
- City of Hope Comprehensive Cancer Center
- Collaborators
- National Cancer Institute (NCI)
- Tags
- CAR T Cell, SLAMF7
- Trial Type
- Treatment
- Last Update
- 1 week ago
- SparkCures ID
- 978
- NCT Identifier
- NCT03710421
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.